Albert David Ltd

NSE
ALBERTDAVD •
BUY

1W Return

-%

1M Return

-%

6M Return

-%

1Y Return

-%

3Y Return

-%

Start SIP in Albert David Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
171.32% Gain from 52W Low
45.4
TTM PE Ratio
Below industry Median
11.8
Price to Book Ratio
Below industry Median
2.5
Dividend yield 1yr %
Below industry Median
0.7
TTM PEG Ratio
PEG TTM is less than 1
0.1
RSI
RSI is mid-range
56.8
MFI
MFI is mid-range
47.8

Albert David Ltd shareholding Pattern

Promoter
62%
Foreign Institutions
0.7%
Domestic Institutions
1.7%
Public
35.6%

Albert David Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
11
Bearish Moving Averages
5
5Day EMA
1,381.40
10Day EMA
1,379.60
12Day EMA
1,376.60
20Day EMA
1,351.10
26Day EMA
1,325.30
50Day EMA
1,226.90
100Day EMA
1,086.60
200Day EMA
931.00
Delivery & Volume
Resistance & Support
1,371.07
Pivot
Resistance
First Resistance
1,395.08
Second Resistance
1,417.42
Third Resistance
1,441.43
Support
First Support
1,348.73
Second support
1,324.72
Third Support
1,302.38
Relative Strength Index
56.75
Money Flow Index
47.79
MACD
51.28
MACD Signal
66.87
Average True Range
76.50
Average Directional Index
26.11
Rate of Change (21)
7.97
Rate of Change (125)
78.12

Albert David Ltd Company background

Founded in: 1938
Managing director: U. M. Kunte
Albert David Limited (ADL), a Unit of Kothari Group, was incorporated in 1938 at Calcutta. The Company belongs to a renowned industrial house of Kolkata, the Kothari Group. The Companys principal business is manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export. Apart from these, it manufactures disposable syringes and needles and a wide range of bulk drugs. It is recognised as a large IV fluid manufacturer, both in glass and polyethylene containers.ADL has entered into a technical collaboration with Morishita Pharmaceuticals, Japan, a subsidiary of Ajinomoto the world leader in amino acids to manufacture amino acid infusions, for which it came out with a rights issue in Aug.87. It has also set up a new unit in Kalyani, West Bengal, to manufacture bulk drugs, which went on stream in 1990. Another rights issue in Mar.90 augmented the longterm working capital. ADL has entered into technical collaboration with Pharma Plan, Germany, to supply machinery to manufacture 30 mln disposable syringes and 70 mln needles at Mandideep near Bhopal. ADL came up with a Rs 4.68cr right issue to part finance the expansion of its capacity of IV fluids in plastic bottles (FFS technology) at Ghaziabad.During 199899, the company has developed some new products viz. Siozole Capsules and FerrochelateZCapsules with Iron Zinc and folic acid in sustained released formulation. In 200203 the company has launched new productsINTECAR,NIMERILT,EVICT,ALROF50. It is also planning to launch new products such as SIOOXY,ALAMIN FEZ,PANSURE.New products were launched such as INTECAR Capsules, NIMERILT, EVICT, ALROF50, ADLIN and SLOZIN during the year 2003 new products such as AlaminFeZ and Pansure were introduced in 2004. SIOOXY (AntiOxidant with OMEGA3 Fatty Acid) was launched in 2005, launched ALAMTNXtra, VERBET the antivertigo drug and water for injection during year 2006 launched Antibiotic Azithromycin under brand AZ3 and expanded its Vision Care range (launched Antiglaucoma products, Antiinfectives, Irrigating Solution and Steroidal combinations) in 2009 launched uterine tonicSiocare and Laxative combinationEvict Fibre and has also expanded its Antiinflammatory Analgesic range with launch of Anaflam XP in 2010 launched Rabeprazole and its combination (AntiPeptic Ulcerant range) and Montelukast and its combination (Anti Asthmatic range) in 2013 launched Alamin Liquid and Alamin RLD (LArginine Sachet) in 2014 launched Dhup Tab Drop (Vit.D3), InbalanseZ (probiotic) and EvictXF (Laxative) in 2015 launched Sioneuron M/PG capsules, InbalanseZ capsules and BreazeFx tablet in 2017. It introduced two products i.e., Evacure and C3H in the market during year 202122.
Read More

Albert David Ltd FAQs

Albert David Ltd shares are currently priced at 1372.75 on NSE and 1370.75 on BSE as of 2/20/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Albert David Ltd [ALBERTDAVD] share was 145.11. The Albert David Ltd [ALBERTDAVD] share hit a 1-year low of Rs. 505.95 and a 1-year high of Rs. 1607.9.

The market cap of Albert David Ltd is Rs. 783.84 Cr. as of 2/20/2024 12:00:00 AM.

The PE ratios of Albert David Ltd is 11.82 as of 2/20/2024 12:00:00 AM.

The PB ratios of Albert David Ltd is 2.23 as of 2/20/2024 12:00:00 AM

The Mutual Fund Shareholding was 0.01% at the end of 2/20/2024 12:00:00 AM.

You can easily buy Albert David Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage